Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Haloperidol, clopenthixol, and chlorpromazine in chronic schizophrenia. Chemically unrelated antipsychotics as therapeutic alternatives.

× No keyword cloud information.

9 in total

Review 1. Zuclopenthixol dihydrochloride for schizophrenia.

Authors: Edward J Bryan; Marie Ann Purcell; Ajit Kumar
Journal: Cochrane Database Syst Rev Date: 2017-11-16

2. Attention and clinical symptoms in schizophrenia.

Authors: B Cornblatt; M Obuchowski; D B Schnur; J D O'Brien
Journal: Psychiatr Q Date: 1997

3. Placebo response in antipsychotic clinical trials: a meta-analysis.

Authors: Bret R Rutherford; Emily Pott; Jane M Tandler; Melanie M Wall; Steven P Roose; Jeffrey A Lieberman
Journal: JAMA Psychiatry Date: 2014-12-01 Impact factor: 21.596

4. Oral and long-acting antipsychotics for relapse prevention in schizophrenia-spectrum disorders: a network meta-analysis of 92 randomized trials including 22,645 participants.

Authors: Giovanni Ostuzzi; Federico Bertolini; Federico Tedeschi; Giovanni Vita; Paolo Brambilla; Lorenzo Del Fabro; Chiara Gastaldon; Davide Papola; Marianna Purgato; Guido Nosari; Cinzia Del Giovane; Christoph U Correll; Corrado Barbui
Journal: World Psychiatry Date: 2022-06 Impact factor: 49.548

5. Plasma protein binding of perazine and amitriptyline in psychiatric patients.

Authors: M Brinkschulte; H J Gaertner; H W Schied; U Breyer-Pfaff
Journal: Eur J Clin Pharmacol Date: 1982 Impact factor: 2.953

6. Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study.

Authors: Gail L Daumit; Donald C Goff; Jonathan M Meyer; Vicki G Davis; Henry A Nasrallah; Joseph P McEvoy; Robert Rosenheck; Sonia M Davis; John K Hsiao; T Scott Stroup; Jeffrey A Lieberman
Journal: Schizophr Res Date: 2008-09-04 Impact factor: 4.939

Haloperidol, clopenthixol, and chlorpromazine in chronic schizophrenia. Chemically unrelated antipsychotics as therapeutic alternatives.

Review 1. Zuclopenthixol dihydrochloride for schizophrenia.

2. Attention and clinical symptoms in schizophrenia.

3. Placebo response in antipsychotic clinical trials: a meta-analysis.

4. Oral and long-acting antipsychotics for relapse prevention in schizophrenia-spectrum disorders: a network meta-analysis of 92 randomized trials including 22,645 participants.

5. Plasma protein binding of perazine and amitriptyline in psychiatric patients.

6. Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study.

Review 7. Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses.

8. Imputation methods for missing outcome data in meta-analysis of clinical trials.

Review 9. Zuclopenthixol versus placebo for schizophrenia.